| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1013556 |
Almotriptan Related Compound C (15 mg) (N-methyl-2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine) |
334981-12-3 |
|
| 2933997500 |
|
|
|
| USP-1013567 |
Almotriptan Related Compound D (15 mg) (1-[({3-[2-(dimethylamino)ethyl]indol-5-yl}methyl)sulfonyl]pyrrolidine N-oxide hydrochloride) |
N/A |
|
| 2933997500 |
|
|
|
| USP-1013727 |
Aloin (25 mg) (Aloin A; (S)-10-Beta-D-Glucopyranosyl-1,8-dihydroxy-3-hydroxymethylanthracen-9(10H)-one) |
1415-73-2 |
|
| 2938900000 |
|
|
|
| USP-1013807 |
Alosetron Hydrochloride (200 mg) (2,3,4,5-Tetrahydro-5-methyl-2-[(5-methylimidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one hydrochloride) |
122852-69-1 |
UN2811 |
| USP-1013818 |
Alosetron Related Compound A (25 mg) (5-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one) |
122852-75-9 |
|
| 2933790002 |
|
|
|
| USP-1015019 |
Alprazolam Related Compound A (30 mg) (2-(2-acetylhydrazino)-7-chloro-5-phenyl-3H-1,4-benzodiazepine) |
28910-89-6 |
|
| 2933997500 |
|
|
|
| USP-1016000 |
Alprostadil (25 mg) |
745-65-3 |
UN2811 |
| USP-1017105 |
Altretamine (500 mg) |
645-05-6 |
|
| 2933690000 |
|
|
|
| USP-1042351 |
Formoterol Related Compound A (30 mg) (2-Amino-4-(1-hydroxy-2-((1-(4-methoxyphenyl)propan-2-yl)amino)ethyl)phenol) |
150513-24-9 |
|
| 2922504500 |
|
|
|
| USP-1042373 |
Formoterol Related Compound C (30 mg) (N-(2-Hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl)acetamide fumarate) |
N/A |
|
| 2924296000 |
|
|
|
| USP-1042408 |
Argatroban (350 mg) |
141396-28-3 |
|
| 2935904000 |
|
|
|
| USP-1042419 |
Argatroban Related Compound A (15 mg) ((2R,4R)-1-[N8-nitro- N2-(3-methylquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) |
74874-10-5 |
|
| 2935909550 |
|
|
|
| USP-1042420 |
Argatroban Related Compound B (20 mg) (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1042437 |
Argatroban Related Compound C (20 mg) ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1042500 |
L-Arginine (200 mg) |
74-79-3 |
|
| 2925299000 |
|
|
|
| USP-1042554 |
Arginine Ethyl Ester Dihydrochloride (250 mg) |
36589-29-4 |
|
| 2925299000 |
|
|
|
| USP-1042601 |
Arginine Hydrochloride (125 mg) |
1119-34-2 |
|
| 2925299000 |
|
|
|
| USP-1042634 |
Aripiprazole (200 mg) |
129722-12-9 |
|
| 2933790002 |
|
|
|
| USP-1042645 |
Aripiprazole Related Compound B (25 mg) (7-(4-hydroxy-butoxy)-3,4-dihydroquinolin-2(1H)-one) |
889443-20-3 |
|
| 2933790002 |
|
|
|
| USP-1042656 |
Aripiprazole Related Compound C (25 mg) (1-(2,3-dichlorophenyl)piperazine hydrochloride) |
119532-26-2 |
|
| 2933599550 |
|
|
|
| USP-1042689 |
Aripiprazole Related Compound F (25 mg) (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide) |
573691-09-5 |
|
| 2933790002 |
|
|
|
| USP-1042690 |
Aripiprazole Related Compound G (25 mg) (7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}quinolin-2(1H)-one) |
129722-25-4 |
|
| 2933790002 |
|
|
|
| USP-1042703 |
Arsanilic Acid (25 mg) |
98-50-0 |
UN3465 |
| USP-1042714 |
Aripiprazole Related Compound H (25 mg) (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one) |
N/A |
|
| 2933790002 |
|
|
|
| USP-1042747 |
Artemisinin (50 mg) ((3R,5aS,6R,8aS,9R,12S,12aR)-Octahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one) |
63968-64-9 |
|
| 2932206000 |
|
|
|
| USP-1042780 |
Artemether (100 mg) |
71963-77-4 |
|
| 2932999000 |
|
|
|
| USP-1042805 |
Artemether Related Compound B (15 mg) ((3R,5aS,6R,8aS,9R,10R,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin) |
71939-51-0 |
|
| 2932999000 |
|
|
|
| USP-1042850 |
Artesunate (200 mg) |
88495-63-0 |
|
| 2932999000 |
|
|
|
| USP-1042907 |
Articaine (40 mg) |
23964-58-1 |
|
| 2934990005 |
|
|
|
| USP-1042918 |
Articaine Hydrochloride (125 mg) |
23964-57-0 |
|
| 2934990005 |
|
|
|
| USP-1042929 |
Articaine Related Compound A (40 mg) (Methyl 4-methyl-3-[2-(propylamino)acetamido]thiophene-2-carboxylate) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1042930 |
Articaine Related Compound B (25 mg) (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid) |
114176-52-2 |
|
| 2934990005 |
|
|
|
| USP-1042962 |
Articaine Related Compound E (40 mg) (Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate) |
1796888-45-3 |
|
| 2934990005 |
|
|
|
| USP-1043003 |
Ascorbic Acid (1 g) (Vitamin C) |
50-81-7 |
|
| 2936270000 |
|
|
|
| USP-1043105 |
Ascorbyl Palmitate (500 mg) |
137-66-6 |
|
| 2936270000 |
|
|
|
| USP-1043149 |
Ascorbyl Stearate (500 mg) |
10605-09-1 |
|
| 2936270000 |
|
|
|
| USP-1043309 |
Powdered Ashwagandha Root Extract (1 g) |
90147-43-6 |
|
| 1302190200 |
|
|
|
| USP-1043331 |
Asiaticoside (30 mg) |
16830-15-2 |
|
| 2938900000 |
|
|
|
| USP-1043502 |
Asparagine Anhydrous (200 mg) |
70-47-3 |
|
| 2924190002 |
|
|
|
| USP-1043513 |
Asparagine Monohydrate (200 mg) |
5794-13-8 |
|
| 2924190002 |
|
|
|
| USP-1043524 |
Asparagine Related Compound A (10 mg) (2,2′-(3,6-dioxopiperazine-2,5-diyl)diacetamide) |
98490-54-1 |
|
| 2933790002 |
|
|
|
| USP-1043706 |
Aspartame (200 mg) |
22839-47-0 |
|
| 2924296000 |
|
|
|
| USP-1043728 |
Aspartame Related Compound A (25 mg) ([(2S,5S)-5-Benzyl-3,6-dioxopiperazin-2-yl]acetic acid) |
5262/10/2 |
|
| 2933599550 |
|
|
|
| USP-1043750 |
Aspartame Acesulfame (200 mg) |
106372-55-8 |
|
| 2934990005 |
|
|
|
| USP-1043819 |
Aspartic Acid (100 mg) |
56-84-8 |
|
| 2922498050 |
|
|
|
| USP-1044006 |
Aspirin (500 mg) |
50-78-2 |
|
| 2918220000 |
|
|
|
| USP-1044108 |
Astragaloside IV (100 mg) ((3beta,6alpha,9beta,16beta,20R,24S)-16,25-Dihydroxy-3-(beta-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside) |
84687-43-4 |
|
| 2932996560 |
|
|
|
| USP-1044119 |
Astragalus Root Dry Extract (1 g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1044254 |
Atenolol Related Compound A (50 mg) (2-(4-Hydroxyphenyl)acetamide) |
17194-82-0 |
|
| 2924296000 |
|
|
|
| USP-1044265 |
Atenolol Related Compound B (25 mg) (2-[4-(2,3-Dihydroxypropoxy)phenyl]acetamide) |
61698-76-8 |
|
| 2924296000 |
|
|
|
| USP-1044276 |
Atenolol Related Compound C (25 mg) (2-[4-(Oxiran-2-ylmethoxy)phenyl]acetamide) |
29122-69-8 |
|
| 2924296000 |
|
|
|
| USP-1044287 |
Atenolol Related Compound D (25 mg) (2-[4-(3-Chloro-2-hydroxypropoxy)phenyl]acetamide) |
115538-83-5 |
|
| 2924296000 |
|
|
|
| USP-1044298 |
Atenolol Related Compound E (25 mg) (2,2′-{[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(4,1-phenylene)}diacetamide) |
141650-31-9 |
|
| 2924296000 |
|
|
|
| USP-1044334 |
Atazanavir Sulfate (200 mg) |
229975-97-7 |
|
| 2933399095 |
|
|
|
| USP-1044345 |
Atazanavir System Suitability Mixture (25 mg) (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1044356 |
Atazanavir Related Compound A (25 mg) ((S)-2-[(Methoxycarbonyl)amino]-3,3-dimethylbutanoic acid) |
162537-11-3 |
|
| 2924190002 |
|
|
|
| USP-1044367 |
Atenolol Related Compound F (25 mg) (2,2′-[{[(Isopropylazanediyl)bis(2-hydroxypropane-3,1-diyl)]bis(oxy)}bis(4,1-phenylene)]diacetamide) |
87619-83-8 |
|
| 2924296000 |
|
|
|
| USP-1044403 |
Atenolol (200 mg) |
29122-68-7 |
|
| 2924296000 |
|
|
|
| USP-1044469 |
Atomoxetine Hydrochloride (200 mg) |
82248-59-7 |
UN2811 |
| USP-1044470 |
Atomoxetine Related Compound A (10 mg) (3-(Methylamino)-1-phenylpropan-1-ol) |
42142-52-9 |
|
| 2922199695 |
|
|
|
| USP-1044488 |
Atomoxetine Related Compound B (10 mg) (N-Methyl-3-phenyl-3-(m-tolyloxy)propan-1-amine hydrochloride) |
1643684-05-2 |
|
| 2922199695 |
|
|
|
| USP-1044491 |
Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) |
873310-31-7 |
|
| 2922199695 |
|
|
|
| USP-1044516 |
Atorvastatin Calcium (100 mg) |
344423-98-9 |
|
| 2933995300 |
|
|
|
| USP-1044527 |
Atorvastatin Related Compound A (20 mg) (Desfluoro impurity, or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt) |
433289-83-9 |
|
| 2933997500 |
|
|
|
| USP-1044538 |
Atorvastatin Related Compound B (20 mg) (Calcium (3S,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) |
887196-25-0 |
|
| 2933997500 |
|
|
|
| USP-1044549 |
Atorvastatin Related Compound C (20 mg) (Calcium (3R,5R)-7-[2,3-Bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) |
693793-53-2 |
|
| 2933998350 |
|
|
|
| USP-1044550 |
Atorvastatin Related Compound D (10 mg) (Epoxide Impurity, 3-(4-Fluorobenzoyl)-2-isobutyryl-N,3-diphenyloxirane-2-carboxamide) |
148146-51-4 |
|
| 2924296000 |
|
|
|
| USP-1044571 |
Atorvastatin Related Compound E (10 mg) (Calcium(3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate (1:2)) |
1105067-88-6 |
|
| 2933998350 |
|
|
|
| USP-1050982 |
Benzalkonium Bromide (C12) (150 mg) (Benzyldodecyldimethylammonium bromide) (需冷链运输) |
7281/4/1 |
UN2928 |
| USP-1051500 |
Benzethonium Chloride (500 mg) |
121-54-0 |
UN2923 |
| USP-1051602 |
Benzhydrol (50 mg) |
91-01-0 |
|
| 2906290000 |
|
|
|
| USP-1054000 |
Benzocaine (500 mg) |
1994/9/7 |
|
| 2922492050 |
|
|
|
| USP-1055002 |
Benzoic Acid (300 mg) |
65-85-0 |
UN3077 |
| USP-1056130 |
Benzophenone (25 mg) (Diphenylmethanone) |
119-61-9 |
UN3077 |
| USP-1056504 |
1,4-Benzoquinone (200 mg) |
106-51-4 |
UN2587 |
| USP-1057507 |
Benzothiadiazine Related Compound A (100 mg) (4-Amino-6-chloro-1,3-benzenedisulfonamide) |
121-30-2 |
|
| 2935909550 |
|
|
|
| USP-1059058 |
Benzphetamine Related Compound E (30 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-phenylpropan-1-ol hydrochloride) |
1591807-86-1 |
|
| 2922190900 |
|
|
|
| USP-1059069 |
Benzphetamine Related Compound F (25 mg) ((1S,2S)-2-[Benzyl(methyl)amino]-1-cyclohexylpropan-1-ol hydrochloride) |
1591761-34-0 |
|
| 2922190900 |
|
|
|
| USP-1061027 |
Benztropine Related Compound A (50 mg) ((1R,3r,5S)-3-(Benzhydryloxy)-8-azabicyclo[3.2.1]octane hydrochloride) |
25471-67-4 |
|
| 2939800000 |
|
|
|
| USP-1298117 |
Granisetron Related Compound A (15 mg) (2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2H-indazole-3-carboxamide) |
127472-42-8 |
|
| 2933399095 |
|
|
|
| USP-1298128 |
Granisetron Related Compound B (15 mg) (N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide) |
107007-95-4 |
|
| 2933399095 |
|
|
|
| USP-1298139 |
Granisetron Related Compound C (15 mg) (N-[(1R,3r,5S)-9-azabicyclo[3.3.1]non-3-yl]-1-methyl-1H-indazole-3-carboxamide hydrochloride) |
141136-01-8 |
|
| 2933399095 |
|
|
|
| USP-1298140 |
Granisetron Related Compound D (15 mg) (1-Methyl-1H-indazole-3-carboxylic acid) |
50890-83-0 |
|
| 2933998350 |
|
|
|
| USP-1298150 |
Granisetron Related Compound E (15 mg) ((1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine acetate) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1298208 |
Grape Seeds Oligomeric Proanthocyanidins (500 mg) |
NA |
|
| 3824995595 |
|
|
|
| USP-1298219 |
Purified Grape Seeds Oligomeric Proanthocyanidins (500 mg) |
N/A |
|
| 3824995595 |
|
|
|
| USP-1298401 |
Powdered Decaffeinated Green Tea Extract (300 mg) |
84650-60-2 |
|
| 2101200040 |
|
|
|
| USP-1299007 |
Griseofulvin (200 mg) |
126-07-8 |
|
| 2941906000 |
|
|
|
| USP-1299200 |
Griseofulvin Permeability Diameter (2 g) |
126-07-8 |
|
| 2941906000 |
|
|
|
| USP-1301007 |
Guaifenesin (200 mg) |
93-14-1 |
|
| 2909490000 |
|
|
|
| USP-1301404 |
Guanabenz Acetate (200 mg) |
23256-50-0 |
UN2811 |
| USP-1301801 |
Guanethidine Monosulfate (200 mg) |
645-43-2 |
|
| 2933999552 |
|
|
|
| USP-1302101 |
Guanfacine Hydrochloride (125 mg) |
29110-48-3 |
UN2811 |
| USP-1302134 |
Guanidine Hydrochloride (100 mg) |
1950/1/1 |
|
| 2925299000 |
|
|
|
| USP-1302156 |
Guanine (100 mg) |
73-40-5 |
|
| 2933599550 |
|
|
|
| USP-1340086 |
Indole (25 mg) |
120-72-9 |
UN2811 |
| USP-1340960 |
Inositol (500 mg) |
87-89-8 |
|
| 2906130000 |
|
|
|
| USP-1341001 |
Indomethacin (200 mg) |
53-86-1 |
UN2811 |
| USP-1343007 |
Iodipamide (200 mg) |
606-17-7 |
|
| 2924296000 |
|
|
|
| USP-1343517 |
Iodixanol (200 mg) |
92339-11-2 |
|
| 2924296000 |
|
|
|
| USP-1343540 |
Iodixanol Related Compound C (25 mg) (5-[Acetyl[3-[[3,5-bis[[(2,3-dihydroxypropyl)amino]carbonyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N’-bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) |
171897-74-8 |
|
| 2924296000 |
|
|
|
| USP-1343550 |
Iodixanol Related Compound D (50 mg) (5-[Acetyl(2-hydroxy-3-methoxypropyl)amino]-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) |
89797-00-2 |
|
| 2924296000 |
|
|
|
| USP-1343561 |
Iodixanol Related Compound E (25 mg) (5-{N-[3-(N-{3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide) |
255376-57-9 |
|
| 2924296000 |
|
|
|
| USP-1344305 |
o-Iodohippuric Acid (100 mg) |
147-58-0 |
|
| 2924296000 |
|
|
|
| USP-1344509 |
Iodoquinol (100 mg) |
83-73-8 |
|
| 2933492250 |
|
|
|
| USP-1344600 |
Iohexol (550 mg) |
66108-95-0 |
|
| 2924296000 |
|
|
|
| USP-1344622 |
Iohexol Related Compound A (100 mg) (5-(acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) |
31127-80-7 |
|
| 2924296000 |
|
|
|
| USP-1344644 |
Iohexol Related Compound B (50 mg) (5-amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide) |
76801-93-9 |
|
| 2924296000 |
|
|
|
| USP-1344666 |
Iohexol Related Compound C (50 mg) (N,N’-bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide) |
N/A |
|
| 2924296000 |
|
|
|
| USP-1344702 |
Iopamidol (200 mg) |
60166-93-0 |
|
| 2924296000 |
|
|
|
| USP-1344724 |
Iopamidol Related Compound A (50 mg) (N,N’-Bis-(1,3-dihydroxy-2-propyl)-5-amino-2,4,6-triiodoisophthalamide) |
60166-98-5 |
|
| 2924296000 |
|
|
|
| USP-1344735 |
Iopamidol Related Compound B (50 mg) (5-Glycolamido-N,N’-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodoisophthalamide) |
N/A |
|
| 2924296000 |
|
|
|
| USP-1344746 |
Iopamidol Related Compound C (40 mg) (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide) |
NA |
|
| 2924296000 |
|
|
|
| USP-1344804 |
Iopromide (400 mg) |
73334-07-3 |
|
| 2924296000 |
|
|
|
| USP-1344826 |
Iopromide Related Compound A (50 mg) (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide) |
154361-51-0 |
|
| 2924296000 |
|
|
|
| USP-1344837 |
Iopromide Related Compound B (50 mg) (5-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide) |
76350-28-2 |
|
| 2924296000 |
|
|
|
| USP-1345002 |
Iothalamic Acid (200 mg) |
2276-90-6 |
|
| 2924296000 |
|
|
|
| USP-1345104 |
Ioversol (200 mg) |
87771-40-2 |
|
| 2924296000 |
|
|
|
| USP-1345159 |
Ioxaglic Acid (100 mg) |
59017-64-0 |
|
| 2924296000 |
|
|
|
| USP-1345206 |
Ioxilan (400 mg) |
107793-72-6 |
|
| 2924296000 |
|
|
|
| USP-1347507 |
Ipratropium Bromide (200 mg) |
66985-17-9 |
|
| 2939790000 |
|
|
|
| USP-1347529 |
Ipratropium Bromide Related Compound B (10 mg) ((1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane, bromide) |
58073-59-9 |
|
| 2939800000 |
|
|
|
| USP-1347530 |
Ipratropium Bromide Related Compound C (15 mg) ((2-RS)-3-hydroxy-2-phenylpropanoic acid) |
552-63-6 |
|
| 2918195000 |
|
|
|
| USP-1347609 |
Irinotecan Hydrochloride (100 mg) |
136572-09-3 |
|
| 2939800000 |
|
|
|
| USP-1347610 |
Irinotecan Related Compound A (10 mg) ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) |
19685-09-7 |
|
| 2939800000 |
|
|
|
| USP-1347631 |
Irinotecan Related Compound B (10 mg) ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) |
86639-52-3 |
|
| 2939800000 |
|
|
|
| USP-1347642 |
Irinotecan Related Compound C (10 mg) (11-Ethyl-4-hydroxy-4-methyl-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl (1,4′-bipiperidine)- 1′-carboxylate hydrochloride) |
N/A |
|
| 2939800000 |
|
|
|
| USP-1347653 |
Irinotecan Related Compound D (15 mg) ((R)-9-[(1,4′-Bipiperidine)-1′-carbonyloxy]-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline hydrochloride, trihydrate) |
N/A |
|
| 2939800000 |
|
|
|
| USP-1347664 |
Irinotecan Related Compound E (15 mg) ((S)-4,11-Diethyl-4-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione) |
78287-27-1 |
|
| 2939790000 |
|
|
|
| USP-1347700 |
Irbesartan (200 mg) |
138402-11-6 |
|
| 2933995300 |
|
|
|
| USP-1347711 |
Irbesartan Related Compound A (25 mg) (1-pentanoylamino-cyclopentanecarboxylic acid [2′-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide) |
748812-53-5 |
|
| 2933998350 |
|
|
|
| USP-1347813 |
Isobutylidene Diurea (300 mg) (1,1′-(2-Methylpropane-1,1-diyl)diurea) |
6104-30-9 |
|
| 2924190002 |
|
|
|
| USP-1348033 |
Isochlorogenic Acid A (50 mg) |
89919-62-0 |
|
| 2918290000 |
|
|
|
| USP-1348543 |
Isoeugenyl Acetate (150 mg) |
93-29-8 |
|
| 2915399500 |
|
|
|
| USP-1348601 |
Red Clover Aerial Parts Isoflavone Aglycones Dry Extract (500 mg) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1348907 |
Isoflupredone Acetate (200 mg) |
338-98-7 |
|
| 2937220000 |
|
|
|
| USP-1606117 |
Rotigotine Related Compound C (25 mg) ((S)-6-{[2-(Thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1606140 |
Rotigotine Related Compound G (25 mg) ((S)-6-{Bis[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride) |
N/A |
|
| 2934990005 |
|
|
|
| USP-1606208 |
Roxarsone (200 mg) |
121-19-7 |
UN3465 |
| USP-1606401 |
Rufinamide (200 mg) |
106308-44-5 |
|
| 2933996500 |
|
|
|
| USP-1606412 |
Rufinamide Related Compound A (25 mg) (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide) |
106308-41-2 |
|
| 2933998350 |
|
|
|
| USP-1606423 |
Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate) |
217448-86-7 |
|
| 2933998350 |
|
|
|
| USP-1606503 |
Rutin (100 mg) |
250249-75-3 |
|
| 2938100000 |
|
|
|
| USP-1607007 |
Saccharin (200 mg) |
1981/7/2 |
|
| 2925110000 |
|
|
|
| USP-1607029 |
Saccharin Calcium (150 mg) |
6485-34-3 |
|
| 2925110000 |
|
|
|
| USP-1607040 |
Saccharin Sodium (200 mg) |
6155-57-3 |
|
| 2925110000 |
|
|
|
| USP-1607506 |
Powdered St. John’s Wort Extract (600 mg) |
84082-80-4 |
|
| 1302190200 |
|
|
|
| USP-1607903 |
D-Salicin (150 mg) |
138-52-3 |
|
| 2938900000 |
|
|
|
| USP-1608000 |
Salicylamide (200 mg) |
65-45-2 |
|
| 2924296000 |
|
|
|
| USP-1609002 |
Salicylic Acid (125 mg) |
69-72-7 |
|
| 2918215100 |
|
|
|
| USP-1609013 |
Salicylic Acid Related Compound A (100 mg) (4-hydroxybenzoic acid) |
99-96-7 |
|
| 2918290000 |
|
|
|
| USP-1612426 |
Sesame Oil Related Compound B (12 mg x 2 vials) ((1,2-Dilinoleoyl-3-palmitoyl-rac-glycerol) (PLL)) |
2190-15-0 |
|
| 1516200100 |
|
|
|
| USP-1612459 |
Sevelamer Carbonate (100 mg) |
845273-93-0 |
|
| 3911906100 |
|
|
|
| USP-1612506 |
L-Serine (200 mg) |
56-45-1 |
|
| 2922505000 |
|
|
|
| USP-1612517 |
Sertraline Hydrochloride Racemic Mixture (30 mg) ((1RS,4RS)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) |
79617-89-3 |
UN3077 |
| USP-1612528 |
Sertraline Hydrochloride Related Compound A (25 mg) ((1RS,4SR)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride) |
N/A |
|
| 2921490002 |
|
|
|
| USP-1612539 |
Sertraline Hydrochloride (100 mg) |
79559-97-0 |
UN3077 |
| USP-1612561 |
Sildenafil Citrate (100 mg) |
171599-83-0 |
|
| 2933595960 |
|
|
|
| USP-1612608 |
Silver Sulfadiazine (200 mg) |
22199-08-2 |
|
| 2843290100 |
|
|
|
| USP-1612619 |
N-Acetylneuraminic Acid (200 mg) |
131-48-6 |
|
| 2932999000 |
|
|
|
| USP-1612630 |
Silybin (50 mg) |
22888-70-6 |
|
| 2932996560 |
|
|
|
| USP-1612641 |
Silydianin (30 mg) |
29782-68-1 |
|
| 2932996560 |
|
|
|
| USP-1612685 |
Sildenafil Related Compound A (10 mg) (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine) |
1391053-95-4 |
|
| 2933599550 |
|
|
|
| USP-1612700 |
Simvastatin (200 mg) |
79902-63-9 |
UN3077 |
| USP-1612743 |
Sirolimus System Suitability Mixture (15 mg) |
N/A |
UN3077 |
| USP-1612765 |
Sirolimus (50 mg) |
53123-88-9 |
UN3077 |
| USP-1612801 |
Sisomicin Sulfate (500 mg) |
53179-09-2 |
|
| 2941901010 |
|
|
|
| USP-1612856 |
Sibutramine Related Compound A (20 mg) (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride) |
N/A |
|
| 2921490002 |
|
|
|
| USP-1614363 |
Sodium Lauryl Sulfate (1 g) |
151-21-3 |
UN1325 |
| USP-1614374 |
Sodium Lauroyl Sarcosinate (150 mg) |
137-16-6 |
UN2811 |
| USP-1614385 |
Sodium Myristoyl Sarcosinate (30 mg) (Sodium N-methyl-N-tetradecanoylglycinate) |
30364-51-3 |
UN2811 |
| USP-1614396 |
Sodium Metabisulfite (2 X 500 mg) |
7681-57-4 |
|
| 2832100000 |
|
|
|
| USP-1614421 |
Sodium Molybdate Dihydrate (200 mg) |
10102-40-6 |
|
| 2841700000 |
|
|
|
| USP-1614454 |
Sodium Nitrite (1 g) |
7632-00-0 |
UN1500 |
| USP-1614501 |
Sodium Nitroprusside (500 mg) |
13755-38-9 |
UN1588 |
| USP-1614512 |
Sodium Phenylbutyrate (200 mg) |
1716-12-7 |
|
| 2916399000 |
|
|
|
| USP-1614523 |
Phenylbutyrate Related Compound A (25 mg) (4-oxo-4-phenylbutanoic acid) |
2051-95-8 |
|
| 2918300000 |
|
|
|
| USP-1235820 |
Enoxaparin Sodium (300 mg) |
679809-58-6 |
|
| 3001900190 |
|
|
|
| USP-1235853 |
Enoxaparin Sodium Molecular Weight Calibrant A (8.0 mg) |
N/A |
|
| 3001900190 |
|
|
|
| USP-1235864 |
Enoxaparin Sodium Molecular Weight Calibrant B (6.0 mg) |
9041/8/1 |
|
| 3001900190 |
|
|
|
| USP-1235900 |
Enrofloxacin (200 mg) |
93106-60-6 |
UN3077 |
| USP-1235911 |
Enrofloxacin Related Compound Mixture (50 mg) |
N/A |
UN3077 |
| USP-1235933 |
Entacapone (200 mg) |
130929-57-6 |
|
| 2926900005 |
|
|
|
| USP-1235944 |
Entacapone Related Compound A (25 mg) ((Z)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylacrylamide) |
145195-63-7 |
|
| 2926900005 |
|
|
|
| USP-1235966 |
Entecavir Monohydrate (200 mg) |
209216-23-9 |
|
| 2933595960 |
|
|
|
| USP-1235977 |
Entecavir Related Compound A (15 mg) (9-[(1S,3R,4S)-4-Dimethylphenylsilyl-3-(benzyloxymethyl)-2-methylenecyclopentyl]guanine) |
649761-24-0 |
|
| 2933599550 |
|
|
|
| USP-1235988 |
Entecavir System Suitability Mixture (15 mg) (This is a mixture containing entecavir 1-epimer (0.2%), entecavir (99.6%), 8-hydroxy entecavir (0.1%), and 8-methoxy entecavir (0.1%)) |
1367369-78-5 |
|
| 3822190000 |
|
|
|
| USP-1236506 |
4-Epianhydrotetracycline Hydrochloride (50 mg) |
4465-65-0 |
|
| 2941300000 |
|
|
|
| USP-1236620 |
(-)-Epicatechin (50 mg) |
490-46-0 |
|
| 2932996560 |
|
|
|
| USP-1236663 |
Epicoprostanol (200 mg) |
516-92-7 |
|
| 2906130000 |
|
|
|
